David Bell, senior scholar at the Brownstone Institute, is a U.S.-based public health physician. After working in internal medicine and public health in Australia and the UK, he worked in the World Health Organization as program head for malaria and febrile diseases at the Foundation for Innovative New Diagnostics in Geneva, and as director of global health technologies at Intellectual Ventures Global Good Fund in Bellevue, Wash. He consults on biotech and global health.
Commentary “Attempting to control mucosal respiratory viruses with systemically administered non-replicating vaccines has thus far been largely unsuccessful.”—Dr. ...
Commentary The rapidly-growing pandemic preparedness industry is dominating global public health and proving increasingly lucrative. To support this ...
Commentary We're assured by the World Health Organization (WHO), the World Bank, the G-20, and their friends that pandemics pose an existential threat to ...
Commentary The Lancet recently released its long-awaited COVID-19 commission report. The report well reflects the current state of public health science ...
Commentary Skeptics of the growing "pandemic prevention, preparedness, and response" (PPR) agenda celebrated recently, heralding a perceived "defeat" ...
